Fresh analysis suggests that patients who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Findings released in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"Users buying these medications should be aware of the risk of rapid rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment weight within about a year and a half.
Analyzing Treatments
The analysis, which examined 37 of studies involving thousands of patients, compared the effects of the injectable medications with older methods.
Scientists point out that people who shed pounds through diet and exercise typically have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists suggest the way of the jabs explains the accelerated rebound.
These medications imitate a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making overeating much more probable."
A Lifelong Issue?
Health authorities advise the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts argue that, due to the significant potential of relapse, the therapy might need to be long-term.
This perspective is echoed by drug manufacturers, who note that the results "highlight the long-term nature of obesity," akin to managing conditions like hypertension.
Patient Accounts
Users who have come off the medication describe a sudden resurgence of hunger.
"It was like a trigger that goes on and you're instantly extremely hungry," recalled an individual.
The struggle is worsened if users have not developed sustainable lifestyle or habit changes during treatment.
Growing Use
Recent estimates suggest that a significant number of people in the UK have used these injections in the past year, with desire being substantial.
- Use is higher among females compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are potent agents for shedding pounds, they are not a magic fix and long-term success hinges on ongoing lifestyle support.
